Critical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness
- 1Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow 107031, Russia
Abstract
Background/Objectives: A globally recognized definition of chronic critical illness (CCI) is lacking. Temporal criteria produce variable estimates, while pathophysiological models emphasize inflammation, catabolism, and immunosuppression (ICS). The relationship between ICS dynamics and mortality remains unclear. Methods: This retrospective single-center cohort study analyzed real-world data from 3374 adult intensive care unit (ICU) patients. CCI was defined by first detection of the ICS triad: C-reactive protein (CRP) >20 mg/L, albumin <30 g/L, and absolute lymphocyte count <0.8 × 109/L within 24 h. CCI days were classified as critical or non-critical. Mortality and mortality density were compared across CCI groups and periods. Results: CCI developed in 820 patients (24.3%) and was associated with higher mortality (relative risk (RR) 5.08) and mortality density (incidence rate ratio (IRR) 4.09). Critical periods comprised 22.15% of CCI patient-days and had higher mortality density than non-critical periods (IRR 4.25) and no CCI (IRR 10.10). Conclusions: CCI appears to be a biologically dynamic condition characterized by alternating critical and non-critical periods. Periods of simultaneous inflammation, catabolism, and immunosuppression are associated with the highest mortality density, while elevated mortality persists even during periods of partial biological compensation. These findings support the concept that the current ICS state may reflect clinically relevant changes in the course of CCI. However, they do not establish diagnostic or predictive performance and require external validation.
Related
- The Critical Clock: Time-Dependent Inflammation, Catabolism and Immunosuppression Syndrome Is Associated with ICU Mortality
- Large Eating Episodes, Cannabis Use, and Health in US Adults: A Cross-Sectional and Exploratory Mortality Analysis
- MAGI3 Acts as an Intestinal Epithelial Gatekeeper in Inflammation‐Associated Colorectal Cancer by Suppressing the STAT3‐CCL2 Axis and TAM‐Mediated Immunosuppression
- Comparative Associations of Inflammation and Nutrition-Based Indices with No-Reflow and Mortality After Primary PCI for ST-Elevation Myocardial Infarction
- Systemic coagulation inflammation index and risk of mortality in peritoneal dialysis patients: a multicenter cohort study
BibTeX
@article{likhvantsev2026critical,
title = {{Critical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness}},
author = {Valery Likhvantsev and Levan Berikashvili and Petr Polyakov and Mikhail Yadgarov and Alexey Yakovlev and Andrey Grechko},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15207864},
url = {https://www.mdpi.com/2077-0383/15/20/7864},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Critical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness
AU - Valery Likhvantsev
AU - Levan Berikashvili
AU - Petr Polyakov
AU - Mikhail Yadgarov
AU - Alexey Yakovlev
AU - Andrey Grechko
PY - 2026
DA - 2026/10/12
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15207864
UR - https://www.mdpi.com/2077-0383/15/20/7864
AB - Background/Objectives: A globally recognized definition of chronic critical illness (CCI) is lacking. Temporal criteria produce variable estimates, while pathophysiological models emphasize inflammation, catabolism, and immunosuppression (ICS). The relationship between ICS dynamics and mortality remains unclear. Methods: This retrospective single-center cohort study analyzed real-world data from 3374 adult intensive care unit (ICU) patients. CCI was defined by first detection of the ICS triad: C-reactive protein (CRP) >20 mg/L, albumin <30 g/L, and absolute lymphocyte count <0.8 × 109/L within 24 h. CCI days were classified as critical or non-critical. Mortality and mortality density were compared across CCI groups and periods. Results: CCI developed in 820 patients (24.3%) and was associated with higher mortality (relative risk (RR) 5.08) and mortality density (incidence rate ratio (IRR) 4.09). Critical periods comprised 22.15% of CCI patient-days and had higher mortality density than non-critical periods (IRR 4.25) and no CCI (IRR 10.10). Conclusions: CCI appears to be a biologically dynamic condition characterized by alternating critical and non-critical periods. Periods of simultaneous inflammation, catabolism, and immunosuppression are associated with the highest mortality density, while elevated mortality persists even during periods of partial biological compensation. These findings support the concept that the current ICS state may reflect clinically relevant changes in the course of CCI. However, they do not establish diagnostic or predictive performance and require external validation.
SN - 2077-0383
ER -